title: Adrenal gland enhancement at MR imaging with Mn-DPDP.
abstract: OBJECTIVE
  To determine adrenal gland enhancement with manganese (II) N,N' dipyridoxylethylenediamine-N,N'-diacetate 5,5'bis(phosphate) (DPDP) at magnetic resonance imaging.
  
  
  METHODS
  After phase III trials, fat-suppressed, motion-compensated, T1-weighted spin-echo images (repetition time, 500 msec; echo time, 12 msec) of 13 consecutive patients were obtained at 1.5 T at one site, prior to and approximately 30 minutes after intravenous administration of 5 mumol/kg Mn-DPDP. Images were analyzed visually and by means of region-of-interest measurements, normalized to spleen. With data added from three more sites, enhancement of three adrenal adenomas and two metastases was analyzed.
  
  
  RESULTS
  Twenty-five of 26 adrenal glands were depicted on MR images, and all showed enhancement. Mean adrenal enhancement (38%) was comparable to mean enhancement of liver (46%), pancreas (25%), and renal cortex (58%). Adrenal cortex and medulla could not be distinguished in nonenhanced or enhanced images. All three adrenal adenomas enhanced by more than 40%, but the metastases did not enhance.
  
  
  CONCLUSIONS
  Functioning adrenal tissue (glands and at least some adenomas) are enhanced with Mn-DPDP.
authors.affiliation: Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, PA.
authors.forename: D G
authors.initials: DG
authors.lastname: Mitchell
authors.forename: E K
authors.initials: EK
authors.lastname: Outwater
authors.forename: T
authors.initials: T
authors.lastname: Matteucci
authors.forename: D L
authors.initials: DL
authors.lastname: Rubin
authors.forename: J L
authors.initials: JL
authors.lastname: Chezmar
authors.forename: S
authors.initials: S
authors.lastname: Saini
mesh_terms: D000236:Adenoma / Q000175:diagnosis*; D000310:Adrenal Gland Neoplasms / Q000175:diagnosis* / Q000556:secondary; D000311:Adrenal Glands / Q000473:pathology*; D003287:Contrast Media; D004492:Edetic Acid / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D008099:Liver / Q000473:pathology; D008103:Liver Cirrhosis / Q000175:diagnosis; D008107:Liver Diseases / Q000175:diagnosis; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008875:Middle Aged; D011732:Pyridoxal Phosphate / Q000031:analogs & derivatives*
chemical_list: D003287:Contrast Media; D011732:Pyridoxal Phosphate; D004492:Edetic Acid; C060076:N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid